Cardiovascular diseases
Group leader
José Luis Zamorano Gómez
zamorano(ELIMINAR)@secardiologia.es https://jlzamorano.com/
Tlf.: +34 91 336 8515
Principal Investigators
- Luis Miguel Rincón Díaz
- Marcelo Sanmartin Fernandez
- Carlos Zaragoza Sánchez
- Rosa Hernández Antolín
- Maria del Carmen de Pablo Zarzosa
- Antonio Hernández Madrid
- Javier Angulo Frutos
- Silvia Martín Puig
Collaborators
- Covadonga Fernández-Golfín Loban
- Vivencio Barrios Alonso
- Manuel Jiménez Mena
- José Luis Moya Mur
- Eduardo González Ferrer
- Javier Moreno Planas
- Marta Saura Redondo
- Miguel Castillo Orive
- Eduardo Franco Díez
- Ana García Martín
- Ariana González Gómez
- Rocío Hinojar Baydes
- José Julio Jiménez Nacher
- Roberto Matia Frances
- Mª Luisa Salido Tahoces
- Elisa Velasco Valdazo
- Gonzalo Luis Alonso Salinas
- Beatriz Escobar Rodríguez
- Rafael Ramirez Carracedo
- Laura Tesoro Santos
- Ignacio Hernández Navarro
- Javier Díez Mata
- Vanesa Cristina Lozano Granero
- Ana Pardo Sanz
Group leader
José Luis Zamorano Gómez
zamorano(ELIMINAR)@secardiologia.es https://jlzamorano.com/
Tlf.: +34 91 336 8515
Principal Investigators
- Luis Miguel Rincón Díaz
- Marcelo Sanmartin Fernandez
- Carlos Zaragoza Sánchez
- Rosa Hernández Antolín
- Maria del Carmen de Pablo Zarzosa
- Antonio Hernández Madrid
- Javier Angulo Frutos
- Silvia Martín Puig
Collaborators
- Covadonga Fernández-Golfín Loban
- Vivencio Barrios Alonso
- Manuel Jiménez Mena
- José Luis Moya Mur
- Eduardo González Ferrer
- Javier Moreno Planas
- Marta Saura Redondo
- Miguel Castillo Orive
- Eduardo Franco Díez
- Ana García Martín
- Ariana González Gómez
- Rocío Hinojar Baydes
- José Julio Jiménez Nacher
- Roberto Matia Frances
- Mª Luisa Salido Tahoces
- Elisa Velasco Valdazo
- Gonzalo Luis Alonso Salinas
- Beatriz Escobar Rodríguez
- Rafael Ramirez Carracedo
- Laura Tesoro Santos
- Ignacio Hernández Navarro
- Javier Díez Mata
- Vanesa Cristina Lozano Granero
- Ana Pardo Sanz
Strategic objectives
Advance in the knowledge of cardiovascular diseases, which is one of the main causes of mortality in developed countries, via a translational basic clinical research approach. Explore the development of new medical imaging technologies and identify and validate diagnostic, prognostic, prevention and treatment response biomarkers.
Research lines
- Imaging techniques in valvular heart disease and structural cardiopathies.
- Ischemic cardiopathy and structural damage: new biomarkers, molecular imaging and precision medicine.
- Development of new therapies in cardiac arrhythmias.
- Cardiovascular epidemiology, risk factors and rehabilitation.
Location
Cardiology Department
2nd floor left.
Ramón y Cajal University Hospital
Keywords
valve insufficiency; acute coronary syndrome; heart failure; software; cardiovascular image; molecular image; new technologies; arrhythmias; endothelial dysfunction; biomarkers; cardiac rehabilitation; ubiquitin proteasome